Talphera TLPH
NASDAQ TLPH
$1.24 +0.02 (+1.64%)
At close: Sep 10, 2026 · 4:00 PM EDT

Talphera (TLPH) Other Working Capital Changes (2010 - 2026)

Talphera (TLPH) posted Other Working Capital Changes of $683000.0 for Q2 2026, up 334.71% on a QoQ basis from -$291000.0 in Q1 2026, and up 371.03% year-over-year from $145000.0 in Q2 2025.

Analysis

Talphera (TLPH) Other Working Capital Changes (2010 - 2026) Analysis & Trends

Talphera has reported Other Working Capital Changes for 17 years, with the latest figure at $683000.0 in Q2 2026.

  • On a quarterly basis, Other Working Capital Changes rose 371.03% year-over-year to $683000.0 in Q2 2026; TTM through Jun 2026 was $5000.0, a 100.45% increase from a year earlier, with the FY2025 full-year figure at -$35000.0, up 97.87% from the prior year.
  • Other Working Capital Changes was $683000.0 for Q2 2026 at Talphera, up from -$291000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.2 million in Q3 2021, with the low at -$2.8 million in Q2 2020.
  • Average Other Working Capital Changes over 5 years is -$167214.3, with a median of -$46000.0 recorded in 2021.
  • The largest YoY upside for Other Working Capital Changes was 1538.1% in 2023 against a maximum downside of 1744.44% in 2023.
  • Over 5 years, Other Working Capital Changes stood at $76000.0 in 2022, then soared by 1402.63% to $1.1 million in 2023, then slumped by 145.88% to -$524000.0 in 2024, then jumped by 78.05% to -$115000.0 in 2025, then jumped by 693.91% to $683000.0 in 2026.
  • The last three Other Working Capital Changes figures came in at $683000.0 (Q2 2026), -$291000.0 (Q1 2026), and -$115000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Talphera 92.90 Mn 92.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 683,000.00
Jun 30, 2026 683,000.00
Mar 31, 2026 -291,000.00
Mar 31, 2026 -291,000.00
Dec 31, 2025 -115,000.00
Dec 31, 2025 -115,000.00
Sep 30, 2025 -272,000.00
Sep 30, 2025 -272,000.00
Jun 30, 2025 145,000.00
Jun 30, 2025 145,000.00
Mar 31, 2025 207,000.00
Mar 31, 2025 207,000.00
Dec 31, 2024 -524,000.00
Dec 31, 2024 -524,000.00
Sep 30, 2024 -936,000.00
Sep 30, 2024 -936,000.00
Jun 30, 2024 645,000.00
Jun 30, 2024 645,000.00
Mar 31, 2024 -826,000.00
Mar 31, 2024 -826,000.00